
All 102 Combined Holdings of the ARK ETFs - Cathie's Ark
The combined positions, trades, and weights of all companies in Cathie Wood's family of ETFs.
All 32 ARKK Holdings - Cathie's Ark
The positions, trades, and weights of all companies in Cathie Wood's ARKK ETF.
Cathie's Ark
The positions, trades, and weights of all companies in Cathie Wood's ARKK ETF.
$10 Billion Cathie Wood Portfolio / ARK Invest Holdings
Exclusive look into the current portfolio and holdings of Cathie Wood (ARK Invest) with a total portfolio value of $9.92 Billion invested in 564 stocks.
ARK Investment Management Portfolio | Cathie Wood 13F
Heatmaps of the top 13f holdings and a list of the largest trades made by ARK Investment Management, the hedge fund managed by Cathie Wood.
Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks - Yahoo Finance
Apr 22, 2024 · Another hedge fund boss famous for her unique approach to investing is Cathie Wood. While Buffett is somewhat of a consumer staples investor who picks out only those companies that are well...
Here Are the 5 Largest Stock Holdings in All of Cathie Wood's …
Jan 22, 2025 · Ark Invest portfolio manager Cathie Wood runs six different actively managed exchange-traded funds. They're all focused on different technologies, although there's some portfolio overlap....
Cathie Wood Stock Portfolio | ARK Invest Holdings 2024 - Buffett …
Here are some key details about her current portfolio: Cathie Wood is known for her high-conviction bets on innovative growth stocks. Her flagship ARK Innovation ETF (ARKK) has returned over 150% in 2020 but struggled in 2022 amid rising interest rates.
Cathie Wood’s Stock Portfolio: 2025 Stock Picks - Insider Monkey
Feb 6, 2025 · Cathie Wood’s investing strategy is pretty straightforward: her ARK ETFs invest in developing high-tech firms in artificial intelligence, blockchain, medicinal technology, and robotics.
These Are the Top 10 Holdings of Cathie Wood - 24/7 Wall St.
Mar 27, 2023 · Here are the top 10 holdings of Cathie Wood: 10. Intellia Therapeutics. Founded in 2014, it is a clinical stage genome editing company. Wood owns over 9.4 million shares of Intellia Therapeutics...
- Some results have been removed